(AM), a potent vasodllator peptlde, exists m the cardiac ventricle, however, the role of AM m the ventricular tissue remams unknown
any efforts have been made to clarify the mechanisms of growth regulation of the cardiac myocardmm because of comphcatlons of the heart caused by cardiac hypertrophy At the cellular level, cardiac myocytes are known to compensate for increased workload by an Increase m their size but not m their number because these cell? are unable to dlvlde later m life ' Multiple factors such as hemodynamlc overload and humoral factors were shown to be mvolved m the process of the cardiac hypertrophy,2-4 but the detailed mechanism remams to be elucidated AM, a potent vasodllator peptlde first detected m human pheochromocytoma, has slight homology with CGRP' In addltlon to the direct vasodllator actlvlty, AM has been shown to possess a broad spectrum of blologlcal actions such as dluresls, mhlbltlon of aldosterone secretion, and mhlbltlon of prohferatlon of vascular smooth muscle cells '-* A specific RIA revealed that AM circulates m the blood and 1s present m the adrenal medulla, kidney, lung and cardiac ventricle of humans and rats ')I" The plasma AM concentration m patients with essential hypertension or primary aldosteromsm was reported to be higher than that m normotenslve control subjects, suggesting a possible role of AM m acting against further elevation of blood pressure "J' In the cardiac ventricle, AM mRNA 1s expressed at a level comparable to that of the adrenal medulla,'3b'4 and both the AM content and mRNA expression are increased m Dahl salt-sensmve and renovascular hypertensive rats compared to respective controls I516 However, at present, It remains unknown whether the cardiac myocytes secrete AM, and what the role of AM 1s m the cardiac tissue
In the first part of this study, we exammed the production and secretion of AM from cultured neonatal cardiac myocytes In the second, we investigated the effect ofAM on the de novo protein synthesis m these cells by measurmg ['4C] 
Measurement of AM in Conditioned Medium
One mllhhter of the condmoned mechum of the cardiac myocyteq was collected and unmechately acldlfied with acetic acid to a final concentration of 1 0 N The media was heated at 100°C for 10 mmutel to Inactivate proteases and applied to a Sep-Pak Cl8 cartridge (M&pore-Waters)
After the cartridge was washed with 10% CH,CN m 0 1% trlfluoroacetlc acid, the absorbed materials were eluted with 50% CH,CN m 0 1% trlfluoroacetlc acid and lyopluhzed for storage at -30°C Recovery of AM for this extraction procedure was 82%. a rate apparently constant The AM m the media extract was measured by a specific RIA for AM as described previously " The antibody used m ttm RIA recognizes the C-terminal portion of AM with the amide structure and has no croT5-reactlvlty with CGRP or amyhn 9
Characterization of Secreted AM whether the cultured neonatal rat cardiac myocytes secrete AM, we measured the AM concentrations m the condltloned media by using the RIA The cardlomyocytes cultured with serum-free media secreted AM mto the media m a time-dependent manner at a rate of 12 2+-O 5 fmol/lXlO' cells for 48 hours (Fig 1) As shown m the of 10 -' mol/L Ang II or 10% FBS significantly (both, P-C.01) increased the AM secretion, by 115% and 3050/o, respectively. Molecular forms of ir-AM secreted into the medium were characterized by reverse-phase HPLC (Fig 2) . The ir-AM was composed of one major and some minor peaks, and the major peak appeared at an elution position identical to that of synthetic rat AM(l -SO)-NHa, a whole active molecule of the rat AM peptide. For examination of the expression of mRNA for the AM precursor by the cells, 30 pg of total RNA extracted from the myocytes was analyzed by the Northern blot method with a prepro-rat AM cDNA probe. As shown in Thtrty micrograms of total RNA extracted from the cells was analyzed by the standard Northern blot method as described in "Methods." Preparations 1 and 2 of total RNA were independently extracted from the cells isolated from two different groups of neonatal rats.
N-terminal-deleted form of AM. When incubated m serumfree media with these analogues, attenuated the mhibitory AM effect on the protein synthesis m a dosedependent manner (Fig 5A) , whereas AM(22-52) had no effect on the AM action (Fig 5B) .
Action
of Endogenous AM In the exammation of the effect of endogenous AM secreted from the cells, the cardiac myocytes were Incubated with CGRP(8-37), which inhibited the actron of synthetic AM, or with anti-AM monoclonal antibody, which specifically bmds to the C-termmal structure of AM, an important portion for the biological activity.2' As shown in Fig 6A, IO- 
